Expedited Review claims are paid the current Payment Percentage of the Scheduled Value for each disease as outlined in the TDP. Expedited Review is also intended to provide qualifying claimants a fixed and certain claim payment. The current Payment Percentage is 60%.
Halliburton or Non-Harbison-Walker Entity Claims
| Disease Level | Scheduled Value |
|---|---|
| Mesothelioma (Level VIII) | $60,718.95 |
| Lung Cancer 1 (Level VII) | $9,872.14 |
| Other Cancer (Level V) | $8,492.16 |
| Severe Asbestosis (Level IV) | $9,978.29 |
| Asbestosis/Pleural Disease (Level III) | $2,547.65 |
| Asbestosis/Pleural Disease (Level II) | $1,167.67 |
| Other Asbestos Disease (Level I) | $106.15 |
Harbison-Walker Entity Claims
| Disease Level | Scheduled Value |
|---|---|
| Mesothelioma (Level VIII) | $144,897.50 |
| Lung Cancer 1 (Level VII) | $47,662.25 |
| Other Cancer (Level V) | $25,476.48 |
| Severe Asbestosis (Level IV) | $31,314.84 |
| Asbestosis/Pleural Disease (Level III) | $7,642.95 |
| Asbestosis/Pleural Disease (Level II) | $4,033.78 |
| Other Asbestos Disease (Level I) | $318.46 |